Skip to main content
Article thumbnail
Location of Repository

The Necrotic Signal Induced by Mycophenolic Acid Overcomes Apoptosis-Resistance in Tumor Cells

By Gwendaline Guidicelli, Benjamin Chaigne-Delalande, Marie-Sarah Dilhuydy, Benoît Pinson, Walid Mahfouf, Jean-Max Pasquet, François-Xavier Mahon, Philippe Pourquier, Jean-François Moreau and Patrick Legembre
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2675064
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2005). Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitment.
    2. (2007). Barriers to effective TRAILtargeted therapy of malignancy.
    3. (1994). BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death.
    4. (2007). Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling.
    5. (2007). Cell death by necrosis: towards a molecular definition.
    6. (2007). Dominantnegative Fas mutation is reversed by down-expression of c-FLIP.
    7. (1994). ESHAP–an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
    8. (2008). Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.
    9. (1991). Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
    10. (2000). Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.
    11. (2004). Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization.
    12. (2004). Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies.
    13. (1975). Interaction of actin with phalloidin: polymerization and stabilization of F-actin.
    14. (1985). Involvement of the bcl-2 gene in human follicular lymphoma.
    15. (1996). Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.
    16. (2008). Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/ Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL).
    17. (2005). Malignancy after transplantation.
    18. (2002). Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization.
    19. (2004). Microenvironmental interactions and survival of CLL B-cells.
    20. (1998). Mitochondria and apoptosis.
    21. (2006). Molecular pathogenesis of chronic lymphocytic leukemia.
    22. (2007). Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailability.
    23. (2007). Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia.
    24. (2004). Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix.
    25. (2006). Poly(ADPribose) (PAR) polymer is a death signal.
    26. (2002). Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas.
    27. (2005). Prospective registrybased observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil.
    28. (2004). Putting the rap on Akt.
    29. (2007). Recent development of IMP dehydrogenase inhibitors for the treatment of cancer.
    30. (1998). Rho GTPases and the actin cytoskeleton.
    31. (1999). Safety and antitumor activity of recombinant soluble Apo2 ligand.
    32. (1991). Selective up-regulation of type II inosine 59-monophosphate dehydrogenase messenger RNA expression in human leukemias.
    33. (2007). Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis.
    34. (1985). Structural organization of the bcr gene and its role in the Ph’ translocation.
    35. (1999). Suppression of ceramide-mediated apoptosis by HSP70.
    36. (2008). The Immunosuppressor Mycophenolic Acid Kills Activated Lymphocytes by Inducing a Nonclassical Actin-Dependent Necrotic Signal.
    37. (2003). The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis.
    38. (2008). The role of TRAIL death receptors in the treatment of hematological malignancies.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.